- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/17 - LymphocytesLymphocytes BLymphocytes TCellules tueuses naturellesLymphocytes activés par un interféron ou une cytokine
Détention brevets de la classe A61K 35/17
Brevets de cette classe: 11521
Historique des publications depuis 10 ans
|
307
|
476
|
677
|
1037
|
1240
|
1425
|
1619
|
1353
|
1309
|
788
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1155 |
501 |
| The Regents of the University of California | 20195 |
276 |
| The Trustees of the University of Pennsylvania | 4374 |
244 |
| Iovance Biotherapeutics, Inc. | 345 |
199 |
| Board of Regents, The University of Texas System | 5906 |
193 |
| Memorial Sloan-Kettering Cancer Center | 1968 |
181 |
| The Board of Trustees of the Leland Stanford Junior University | 6507 |
133 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2892 |
118 |
| Juno Therapeutics, Inc. | 446 |
116 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 975 |
107 |
| The General Hospital Corporation | 4789 |
98 |
| Baylor College of Medicine | 966 |
90 |
| City of Hope | 1004 |
90 |
| Autolus Limited | 259 |
84 |
| Dana-Farber Cancer Institute, Inc. | 2607 |
83 |
| Cellectis | 402 |
82 |
| Regents of the University of Minnesota | 2722 |
75 |
| Immunitybio, Inc. | 443 |
75 |
| Kite Pharma, Inc. | 409 |
71 |
| Novartis AG | 10685 |
70 |
| Autres propriétaires | 8635 |